Citation: J. Van Der Zee et al., Comments on "Chemoradiation for carcinoma of the cervix: Advances and opportunities" by Patricia Eifel (Radiat. Res. 154, 229-236, 2000), RADIAT RES, 156(2), 2001, pp. 221-222
Authors:
Burger, CW
van Doorn, HC
van der Valk, P
Bonfrer, HMG
Citation: Cw. Burger et al., Oestrogen, progesterone and androgen receptor in ovarian neoplasm: correlation between immunohistochemical and biochemical receptor analyses, EUR J CANC, 36, 2000, pp. S93-S118
Authors:
Verheul, HAM
Coelingh-Bennink, HJT
Kenemans, P
Atsma, WJ
Burger, CW
Eden, JA
Hammar, M
Marsden, J
Purdie, DW
Citation: Ham. Verheul et al., Effects of estrogens and hormone replacement therapy on breast cancer riskand on efficacy of breast cancer therapies, MATURITAS, 36(1), 2000, pp. 1-17
Authors:
van Doorn, HC
Burger, CW
van der Valk, P
Bonfrer, HMG
Citation: Hc. Van Doorn et al., Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses, J CLIN PATH, 53(3), 2000, pp. 201-205
Citation: F. Scheele et al., Postmenopausal hormone replacement in the woman with a reproductive risk factor for breast cancer, MATURITAS, 33(3), 1999, pp. 191-196
Authors:
Kok, ALM
Burger, CW
van de Weijer, PHM
Voetberg, GA
Peters-Muller, ERA
Kenemans, P
Citation: Alm. Kok et al., Micturition complaints in postmenopausal women treated with continuously combined hormone replacement therapy: a prospective study, MATURITAS, 31(2), 1999, pp. 143-149
Citation: Hm. Prinssen et al., Clostridium septicum myonecrosis and ovarian cancer: A case report and review of literature, GYNECOL ONC, 72(1), 1999, pp. 116-119